What's Hot inSynthetic Biology? : vimarsana.com

On this episode of GEN Live, John Cumbers, PhD, CEO of SynBioBeta and Shelby Newsad, PhD, Investor at the Venture Capital firm Compound, join us for a broad discussion on the state of synbio—where the field is now and where it’s heading.

Related Keywords

Shelby Newsad , , Broadcast Date , John Cumbers , Venture Capital ,